Recarbrio ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

recarbrio

merck sharp & dohme b.v.  - imipenem, monohydrat, cilastatin natrium, relebactam monohydrat - gram-negative bakterie-infektioner - carbapenems, antibacterials for systemic use, - recarbrio is indicated for:- treatment of hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap), in adults (see sections 4. 4 og 5. - treatment of bacteraemia that occurs in association with, or is suspected to be associated with hap or vap, in adults. - treatment of infections due to aerobic gram-negative organisms in adults with limited treatment options (see sections 4. 2, 4. 4 og 5. det bør overvejes at officielle vejledning om hensigtsmæssig brug af antibakterielle midler..

Andatin 500+500 mg pulver til infusionsvæske, opløsning ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

andatin 500+500 mg pulver til infusionsvæske, opløsning

macure pharma aps - cilastatinnatrium, imipenem monohydrat - pulver til infusionsvæske, opløsning - 500+500 mg

Valcyte 50 mg/ml pulver til oral opløsning ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

valcyte 50 mg/ml pulver til oral opløsning

cheplapharm arzneimittel gmbh - valganciclovirhydrochlorid - pulver til oral opløsning - 50 mg/ml

Valcyte 450 mg filmovertrukne tabletter ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

valcyte 450 mg filmovertrukne tabletter

cheplapharm arzneimittel gmbh - valganciclovirhydrochlorid - filmovertrukne tabletter - 450 mg